6,6-二甲基双环[3.1.1]庚烷 | 127-92-4

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 中文名称: 6,6-二甲基双环[3.1.1]庚烷
• 英文名称: 6,6-dimethyl-norpinane
• 英文别名: 6,6-Dimethyl-norpinan；6,6-dimethyl-bicyclo[3,1,1]heptane；6,6-dimethyl-bicyclo[3.1.1]heptane；6,6-Dimethyl-bicyclo<3.1.1>heptan；Apopinan；6,6-Dimethylbicyclo[3.1.1]heptane
• CAS: 127-92-4
• 化学式: C₉H₁₆
• 分子量: 124.226
• InChiKey: UCZTUROBDISEKY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

反应信息

• 作为反应物：
  描述：

  6,6-二甲基双环[3.1.1]庚烷 生成 7-甲基-1，6-辛二烯
  参考文献：
  名称：

  Studies in the Terpene Series. XXI.^1a The Thermal Isomerization of 6,6-Dimethylnorpinane at Atmospheric Pressure

  摘要：

  DOI：

  10.1021/ja01646a042
• 作为产物：
  描述：

  7,7-二甲基双环[3.1.1]庚-3-烯 在 铂 氢气 作用下， 生成 6,6-二甲基双环[3.1.1]庚烷
  参考文献：
  名称：

  Bessiere-Chretien,Y.; Grison,C., Bulletin de la Societe Chimique de France, 1971, p. 1454 - 1463

  摘要：

  DOI：

文献信息

• 7-oxabicyclo[2.2.1] heptane sulfonamide derivatives
  申请人：Shionogi & Co., Ltd.

  公开号：US04960909A1

  公开（公告）日：1990-10-02

  Bicyclic sulfonamido derivatives represented by the formula: ##STR1## wherein R.sub.1 is a hydrogen or lower alkyl; R.sub.2 is an alkyl, substituted or unsubstituted aryl, aralkyl or hetelocycle; R.sub.3 is a hydrogen or methyl; X is an alkylene or alkenylene which may be substituted by a fluorine atom or atoms and may contain an oxygen, sulfur and/or phenylene in the chain; Y is straight or branched alkylene or alkenylene oxygen, or sulfur; m is 0 or 1; and n is 0, 1 or 2, or their salt, said derivatives being useful as antithrombotic, anti-vasoconstricting, and anti-bronchoconstricting drugs.

  公式为：##STR1## 的双环磺酰胺衍生物，其中R.sub.1是氢或低碳基；R.sub.2是烷基，取代或未取代的芳基，芳基烷基或杂环基；R.sub.3是氢或甲基；X是可以被氟原子或原子取代的烷基或烯基，可以在链中包含氧、硫和/或苯基；Y是直链或支链烷基或烯基氧或硫；m为0或1；n为0、1或2，或其盐，这些衍生物可用作抗血栓、抗血管收缩和抗支气管收缩药物。
• 6-oxa and thiabicyclo [3.1.0.] compounds
  申请人：Shionogi & Co., Ltd.

  公开号：US05043456A1

  公开（公告）日：1991-08-27

  There are provided compounds of the formula: ##STR1## wherein R.sub.1 is a hydrogen or C.sub.1 -C.sub.5 alkyl; R.sub.2 is an C.sub.1 -C.sub.10 alkyl, aryl, aralkyl, or pyridyl, where the aryl, aralkyl, or pyridyl are unsubstituted or are substituted by C.sub.1 -C.sub.5 alkyl, C.sub.1 -C.sub.5 alkoxy, nitro, hydroxy, carboxy, amino, C.sub.1 -C.sub.5 alkylamino, C.sub.1 -C.sub.5 dialkyamino whose two alkyl groups may be different from each other, C.sub.2 -C.sub.3 alkanoylamino, or halogen and X is an C.sub.1 -C.sub.7 alkylene, C.sub.2 -C.sub.7 alkenylene, --CH(F)CH.dbd.CH(CH.sub.2).sub.3 --, --(CH.sub.2).sub.3 --S--(CH.sub.2).sub.2 --, --(CH.sub.2).sub.2 --S--(CH.sub.2).sub.3 --, --C.sub.6 H.sub.4 -O--CH.sub.2 -- or --CH.sub.2 CH.dbd.CH--m--C.sub.6 H.sub.4 --, or their pharmaceutically accepatble salts. The compounds are useful as antithrombotic, anti-vasconstricting and anti-bronchoconstricting drugs.

  提供的化合物的化学式为：##STR1## 其中R.sub.1为氢或C.sub.1-C.sub.5烷基；R.sub.2为C.sub.1-C.sub.10烷基，芳基，芳基烷基或吡啶基，其中芳基，芳基烷基或吡啶基未经取代或被C.sub.1-C.sub.5烷基，C.sub.1-C.sub.5烷氧基，硝基，羟基，羧基，氨基，C.sub.1-C.sub.5烷基氨基，C.sub.1-C.sub.5二烷基胺（两个烷基可能不同），C.sub.2-C.sub.3烷酰胺，或卤素取代，X为C.sub.1-C.sub.7烷基，C.sub.2-C.sub.7烯基，--CH(F)CH.dbd.CH(CH.sub.2).sub.3 --，--(CH.sub.2).sub.3 --S--(CH.sub.2).sub.2 --，--(CH.sub.2).sub.2 --S--(CH.sub.2).sub.3 --，--C.sub.6 H.sub.4 -O--CH.sub.2 --或--CH.sub.2 CH.dbd.CH--m--C.sub.6 H.sub.4 --，或其药学上可接受的盐。这些化合物可用作抗血栓、抗血管收缩和抗支气管收缩药物。
• Bicyclic sulfonamide derivatives
  申请人：Shionogi & Co., Ltd.

  公开号：US04861913A1

  公开（公告）日：1989-08-29

  Bicyclic sulfonamido derivatives represented by the formula: ##STR1## wherein R.sub.1 is a hydrogen or lower alkyl; R.sub.2 is an alkyl, substituted or unsubstituted aryl, aralkyl or heterocycle; R.sub.3 is a hydrogen or methyl; X is an alkylene or alkenylene which may be substituted by a fluorine atom or atoms an may contain an oxygen, sulfur and/or phenylene in the chain; Y is straight or branched alkylene or alkenylene, oxygen, or sulfur; m is 0 or 1; and n is 0, 1 or 2, or their salt, said derivatives being useful as antithrombotic, anti-vasoconstricting, and anti-bronchoconstricting drugs.

  以下是翻译结果： 公式表示的双环磺酰胺衍生物：##STR1## 其中R.sub.1是氢或较低的烷基；R.sub.2是烷基，取代或未取代的芳基，芳基烷基或杂环；R.sub.3是氢或甲基；X是可以被氟原子取代的烷基或烯基，且链中可能含有氧、硫和/或苯基；Y是直链或支链烷基或烯基、氧或硫；m为0或1；n为0、1或2，或其盐，所述衍生物可用作抗血栓、抗血管收缩和抗支气管收缩药物。
• Study in Terpene Series. XI.¹ The Dehydroxymethylation of Bicyclic Primary Terpenic Alcohols by Hydrogenolysis in the Presence of Nickel Catalysts²
  作者：V. N. Ipatieff、G. J. Czajkowski、Herman Pines

  DOI：10.1021/ja01153a014

  日期：1951.9
• Semmler; Feldstein, Chemische Berichte, 1914, vol. 47, p. 388
  作者：Semmler、Feldstein

  DOI：——

  日期：——

表征谱图